* Can Fite Biopharma Ltd says submits psoriasis phase III
protocol and registration plan to EMA for piclidenoson (CF101)
The post BRIEF-Can Fite Biopharma submits psoriasis phase III protocol appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Can Fite Biopharma Ltd says submits psoriasis phase III
protocol and registration plan to EMA for piclidenoson (CF101)
The post BRIEF-Can Fite Biopharma submits psoriasis phase III protocol appeared first on NASDAQ.